Rosie Mincey
Family · Walterboro, SCNPI 1912350034
Payments from drug & device makers
Across 333 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$792
- Boehringer Ingelheim$703
- Abbott$446
- Lilly USA, LLC$425
- GSK$411
- Merck$352
- plus $3K from 30 others
What the payments were for
- Food & beverage$5,948100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 41 | $792 |
| Boehringer Ingelheim | 38 | $703 |
| Abbott | 19 | $446 |
| Lilly USA, LLC | 27 | $425 |
| GSK | 26 | $411 |
| Merck | 24 | $352 |
| AbbVie | 24 | $348 |
| Novartis | 19 | $292 |
| Bayer | 13 | $262 |
| Exact Sciences | 11 | $211 |
| Novo Nordisk | 12 | $197 |
| Pfizer | 12 | $191 |
| Johnson & Johnson | 13 | $180 |
| Amgen | 11 | $176 |
| Corcept Therapeutics | 8 | $162 |
| Dexcom, Inc. | 4 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $101 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Astellas Pharma US Inc | 3 | $59 |
| Boston Scientific | 1 | $58 |
| Amarin Pharma, Inc. | 2 | $44 |
| Neuraxis, Inc. | 1 | $39 |
| Argenx US, Inc. | 1 | $32 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $28 |
| Rhythm Pharmaceuticals, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,948 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 51 | $66,974 |
| FarxigaDapagliflozin Propanediol | 48 | $57,380 |
| MounjaroTirzepatide | 41 | $53,687 |
| TradjentaLinagliptin | 25 | $36,543 |
| JanuviaSitagliptin Phosphate | 23 | $33,833 |
| EliquisApixaban | 35 | $27,815 |
| OzempicSemaglutide | 21 | $20,340 |
| XareltoRivaroxaban | 23 | $17,229 |
| TrulicityDulaglutide | 11 | $16,623 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $16,248 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $14,171 |
| EntrestoSacubitril/Valsartan | 14 | $13,772 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $5,778 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 20 | $2,540 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,845 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $703 | $103,51776 claims |
| Lilly USA, LLCMounjaro, Trulicity | $425 | $70,31152 claims |
| AstraZenecaFarxiga, Symbicort | $792 | $63,15862 claims |
| MerckJanuvia, Janumet Xr | $352 | $48,00441 claims |
| PfizerEliquis | $191 | $27,81535 claims |
| Novo NordiskOzempic | $197 | $20,34021 claims |
| Johnson & JohnsonXarelto | $180 | $17,22923 claims |
| GSKTrelegy Ellipta | $411 | $16,24815 claims |
| NovartisEntresto | $292 | $13,77214 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $48342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.
Other family in Walterboro
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.